Cargando…

A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis

BACKGROUND: The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite’s genetic heterogeneity as major contributing factors in the development of sy...

Descripción completa

Detalles Bibliográficos
Autores principales: McGregor, Brett A., Razmjou, Elham, Hooshyar, Hossein, Seeger, Drew R., Golovko, Svetlana A., Golovko, Mikhail Y., Singer, Steven M., Hur, Junguk, Solaymani-Mohammadi, Shahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354925/
https://www.ncbi.nlm.nih.gov/pubmed/37464386
http://dx.doi.org/10.1186/s13071-023-05821-1
_version_ 1785075027535724544
author McGregor, Brett A.
Razmjou, Elham
Hooshyar, Hossein
Seeger, Drew R.
Golovko, Svetlana A.
Golovko, Mikhail Y.
Singer, Steven M.
Hur, Junguk
Solaymani-Mohammadi, Shahram
author_facet McGregor, Brett A.
Razmjou, Elham
Hooshyar, Hossein
Seeger, Drew R.
Golovko, Svetlana A.
Golovko, Mikhail Y.
Singer, Steven M.
Hur, Junguk
Solaymani-Mohammadi, Shahram
author_sort McGregor, Brett A.
collection PubMed
description BACKGROUND: The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite’s genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis. METHODS: The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal–Wallis non-parametric test with a post hoc Dunn test. RESULTS: We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite’s genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers. CONCLUSIONS: These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13071-023-05821-1.
format Online
Article
Text
id pubmed-10354925
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103549252023-07-20 A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis McGregor, Brett A. Razmjou, Elham Hooshyar, Hossein Seeger, Drew R. Golovko, Svetlana A. Golovko, Mikhail Y. Singer, Steven M. Hur, Junguk Solaymani-Mohammadi, Shahram Parasit Vectors Research BACKGROUND: The mechanisms underlying the clinical outcome disparity during human infection with Giardia duodenalis are still unclear. In recent years, evidence has pointed to the roles of host factors as well as parasite’s genetic heterogeneity as major contributing factors in the development of symptomatic human giardiasis. However, it remains contested as to how only a small fraction of individuals infected with G. duodenalis develop clinical gastrointestinal manifestations, whereas the majority of infected individuals remain asymptomatic. Here, we demonstrate that diversity in the fecal microbiome correlates with the clinical outcome of human giardiasis. METHODS: The genetic heterogeneity of G. duodenalis clinical isolates from human subjects with asymptomatic and symptomatic giardiasis was determined using a multilocus analysis approach. We also assessed the genetic proximity of G. duodenalis isolates by constructing phylogenetic trees using the maximum likelihood. Total genomic DNA (gDNA) from fecal specimens was utilized to construct DNA libraries, followed by performing paired-end sequencing using the HiSeq X platform. The Kraken2-generated, filtered FASTQ files were assigned to microbial metabolic pathways and functions using HUMAnN 3.04 and the UniRef90 diamond annotated full reference database (version 201901b). Results from HUMAnN for each sample were evaluated for differences among the biological groups using the Kruskal–Wallis non-parametric test with a post hoc Dunn test. RESULTS: We found that a total of 8/11 (72.73%) human subjects were infected with assemblage A (sub-assemblage AII) of G. duodenalis, whereas 3/11 (27.27%) human subjects in the current study were infected with assemblage B of the parasite. We also found that the parasite’s genetic diversity was not associated with the clinical outcome of the infection. Further phylogenetic analysis based on the tpi and gdh loci indicated that those clinical isolates belonging to assemblage A of G. duodenalis subjects clustered compactly together in a monophyletic clade despite being isolated from human subjects with asymptomatic and symptomatic human giardiasis. Using a metagenomic shotgun sequencing approach, we observed that infected individuals with asymptomatic and symptomatic giardiasis represented distinctive microbial diversity profiles, and that both were distinguishable from the profiles of healthy volunteers. CONCLUSIONS: These findings identify a potential association between host microbiome disparity with the development of clinical disease during human giardiasis, and may provide insights into the mechanisms by which the parasite induces pathological changes in the gut. These observations may also lead to the development of novel selective therapeutic targets for preventing human enteric microbial infections. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13071-023-05821-1. BioMed Central 2023-07-18 /pmc/articles/PMC10354925/ /pubmed/37464386 http://dx.doi.org/10.1186/s13071-023-05821-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
McGregor, Brett A.
Razmjou, Elham
Hooshyar, Hossein
Seeger, Drew R.
Golovko, Svetlana A.
Golovko, Mikhail Y.
Singer, Steven M.
Hur, Junguk
Solaymani-Mohammadi, Shahram
A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis
title A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis
title_full A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis
title_fullStr A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis
title_full_unstemmed A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis
title_short A shotgun metagenomic analysis of the fecal microbiome in humans infected with Giardia duodenalis
title_sort shotgun metagenomic analysis of the fecal microbiome in humans infected with giardia duodenalis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354925/
https://www.ncbi.nlm.nih.gov/pubmed/37464386
http://dx.doi.org/10.1186/s13071-023-05821-1
work_keys_str_mv AT mcgregorbretta ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT razmjouelham ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT hooshyarhossein ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT seegerdrewr ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT golovkosvetlanaa ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT golovkomikhaily ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT singerstevenm ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT hurjunguk ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT solaymanimohammadishahram ashotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT mcgregorbretta shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT razmjouelham shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT hooshyarhossein shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT seegerdrewr shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT golovkosvetlanaa shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT golovkomikhaily shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT singerstevenm shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT hurjunguk shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis
AT solaymanimohammadishahram shotgunmetagenomicanalysisofthefecalmicrobiomeinhumansinfectedwithgiardiaduodenalis